Stress Testing Compared to Coronary Computed Tomographic Angiography in Patients With Suspected Coronary Artery Disease

NCT01368770 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2015-04-02

No results posted yet for this study

Summary

The use of coronary computed tomographic angiography(CTA)is rapidly increasing, but there is lack of data which supports their use in the initial evaluation of patients who are asymptomatic or mildly symptomatic. The hypothesis underlying this proposal is that the use of stress-rest myocardial perfusion imaging (MPI) as an initial test for the evaluation of asymptomatic or mildly symptomatic patients who are at intermediate risk of coronary events will result in less further non-invasive and invasive testing and result in reduced costs, without adversely affecting clinical outcomes in the short term.

Conditions

Interventions

OTHER

Coronary CTA

Coronary CTA using standard protocols

OTHER

Stress MPI SPECT

Stress MPI using standard protocols

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Bab El Oued

    collaborator OTHER
  • Hospital Italiano Garibaldi,Rosario ARGENTINA

    collaborator UNKNOWN
  • Pontificia Universidad Catolica de Chile

    collaborator OTHER
  • Fu Wai Hospital, Beijing, China

    collaborator OTHER
  • Instituto de Cardiologia,Bogota D.C. COLOMBIA

    collaborator UNKNOWN
  • Instituto de Cardiologia y Cirugia Cardiovascular,LA Habana CUBA

    collaborator UNKNOWN
  • University Hospital Ostrava

    collaborator OTHER
  • Indian Institute of Public Health, India

    collaborator OTHER
  • Università degli Studi di Brescia

    collaborator OTHER
  • Universidad Nacional Autonoma de Mexico

    collaborator OTHER
  • University Medical Centre Ljubljana

    collaborator OTHER
  • Ankara University

    collaborator OTHER
  • International Atomic Energy Agency

    collaborator OTHER_GOV
  • All India Institute of Medical Sciences

    lead OTHER

Principal Investigators

  • Ganesan Karthikeyan, MD,DM,MSc · All India Institute of Medical Sciences

  • Salah E Bouyoucef · Centre Hospitalier Universitaire de Bab El-Qued

  • Jorge Cachero · Hospital Italiano Garibaldi

  • Rodrigo J Fernández · Universidad Católica de Chile

  • Zuo X He · Fu Wai Hospital, Beijing, China

  • Claudia Teresa G Villamil · Instituto de Cardiologia

  • Amalia T Peix González · Instituto de Cardiologia y Cirugia Cardiovascular

  • Otakar Kraft · University Hospital

  • Niveditha Devasenapathy · Indian Institute of Public Health

  • Davide Farina · Universita di Brescia

  • Aloha Meave · Universidad Nacional Autonoma de Mexico

  • Barbara G Salobir · University Medical Centre

  • Borut Jug · University Medical Centre

  • Elgin Ozkan · Ankara University

  • Maurizio DONDI · International Atomic Energy Agency

  • Ravi KASHYAP · International Atomic Energy Agency

  • Diana PAEZ · International Atomic Energy Agency

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-06-30
Completion
2014-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01368770 on ClinicalTrials.gov